StockStory Highlights Natera, Stryker as Cash Producers; Flags Supernus Concerns

StockStory identified Natera (NTRA) and Stryker (SYK) as cash-producing stocks with potential for long-term success, while expressing caution on Supernus Pharmaceuticals (SUPN). The analysis, published January 26, 2026, is based on free cash flow margins and valuation metrics. Natera, with a 5% trailing free cash flow margin, trades at 13.2x forward price-to-sales. Stryker, with a 16.7% margin, trades at 24.7x forward P/E. Supernus, despite a 10.4% margin, trades at 19.4x forward P/E, which the service cites as a reason it "doesn’t pass our bar." The report promotes a separate list of six stocks that have returned 244% over the past five years.